世界のバイオシミラー医薬品市場2017

【英語タイトル】Global Biosimilar Drug Market Research Report 2017

9Dimen Researchが出版した調査資料(DIMEN7075668)・商品コード:DIMEN7075668
・発行会社(調査会社):9Dimen Research
・発行日:2017年6月14日
・ページ数:163
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名閲覧用)USD2,850 ⇒換算¥322,050見積依頼/購入/質問フォーム
Global/Corporate UserUSD5,800 ⇒換算¥655,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、世界のバイオシミラー医薬品市場2017について調査・分析し、バイオシミラー医薬品の世界市場規模、市場予測、市場動向、上流市場分析、下流市場分析、バイオシミラー医薬品のアジア市場動向、米国市場動向、欧州市場動向、マーケティングチャネル分析、投資可能性分析、バイオシミラー医薬品メーカー分析などを含め、以下の構成でお届けいたします。
・バイオシミラー医薬品の市場概要
・バイオシミラー医薬品の上流・下流市場分析
・バイオシミラー医薬品のアジア市場:市場分析(製品開発、産業政策、競争環境、市場動向等)
・バイオシミラー医薬品のアジア市場:市場規模(生産規模、市場シェア、需要、輸出・輸入等)
・バイオシミラー医薬品のアジア市場:主要メーカー分析(製品、用途、生産量、価格、企業連絡先等)
・バイオシミラー医薬品のアジア市場:市場予測(生産規模、市場シェア、需要、輸出・輸入等)
・バイオシミラー医薬品の北米市場:市場分析(製品開発、産業政策、競争環境、市場動向等)
・バイオシミラー医薬品の北米市場:市場規模(生産規模、市場シェア、需要、輸出・輸入等)
・バイオシミラー医薬品の北米市場:主要メーカー分析(製品、用途、生産量、価格、企業連絡先等)
・バイオシミラー医薬品の北米市場:市場予測(生産規模、市場シェア、需要、輸出・輸入等)
・バイオシミラー医薬品のヨーロッパ市場:市場分析(製品開発、産業政策、競争環境、市場動向等)
・バイオシミラー医薬品のヨーロッパ市場:市場規模(生産規模、市場シェア、需要、輸出・輸入等)
・バイオシミラー医薬品のヨーロッパ市場:主要メーカー分析(製品、用途、生産量、価格、企業連絡先等)
・バイオシミラー医薬品のヨーロッパ市場:市場予測(生産規模、市場シェア、需要、輸出・輸入等)
・バイオシミラー医薬品のマーケティングチャネル分析
・マクロ経済分析(中国経済、欧州経済、アメリカ経済、日本経済、グローバル経済)
・バイオシミラー医薬品の投資可能性分析
・バイオシミラー医薬品の世界市場:生産規模、供給、販売、需要予測
...
【レポートの概要】

Biosimilar Drug Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).

The report firstly introduced the Biosimilar Drug basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The report includes six parts, dealing with:
1.) basic information;
2.) the Asia Biosimilar Drug Market;
3.) the North American Biosimilar Drug Market;
4.) the European Biosimilar Drug Market;
5.) market entry and investment feasibility;
6.) the report conclusion.

【レポートの目次】

Table of Contents

Part I Biosimilar Drug Industry Overview

Chapter One Biosimilar Drug Industry Overview
1.1 Biosimilar Drug Definition
1.2 Biosimilar Drug Classification Analysis
1.2.1 Biosimilar Drug Main Classification Analysis
1.2.2 Biosimilar Drug Main Classification Share Analysis
1.3 Biosimilar Drug Application Analysis
1.3.1 Biosimilar Drug Main Application Analysis
1.3.2 Biosimilar Drug Main Application Share Analysis
1.4 Biosimilar Drug Industry Chain Structure Analysis
1.5 Biosimilar Drug Industry Development Overview
1.5.1 Biosimilar Drug Product History Development Overview
1.5.1 Biosimilar Drug Product Market Development Overview
1.6 Biosimilar Drug Global Market Comparison Analysis
1.6.1 Biosimilar Drug Global Import Market Analysis
1.6.2 Biosimilar Drug Global Export Market Analysis
1.6.3 Biosimilar Drug Global Main Region Market Analysis
1.6.4 Biosimilar Drug Global Market Comparison Analysis
1.6.5 Biosimilar Drug Global Market Development Trend Analysis

Chapter Two Biosimilar Drug Up and Down Stream Industry Analysis
2.1 Upstream Raw Materials Analysis
2.1.1 Upstream Raw Materials Price Analysis
2.1.2 Upstream Raw Materials Market Analysis
2.1.3 Upstream Raw Materials Market Trend
2.2 Down Stream Market Analysis
2.1.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis

Part II Asia Biosimilar Drug Industry (The Report Company Including the Below Listed But Not All)

Chapter Three Asia Biosimilar Drug Market Analysis
3.1 Asia Biosimilar Drug Product Development History
3.2 Asia Biosimilar Drug Competitive Landscape Analysis
3.3 Asia Biosimilar Drug Market Development Trend

Chapter Four 2012-2017 Asia Biosimilar Drug Productions Supply Sales Demand Market Status and Forecast
4.1 2012-2017 Biosimilar Drug Capacity Production Overview
4.2 2012-2017 Biosimilar Drug Production Market Share Analysis
4.3 2012-2017 Biosimilar Drug Demand Overview
4.4 2012-2017 Biosimilar Drug Supply Demand and Shortage
4.5 2012-2017 Biosimilar Drug Import Export Consumption
4.6 2012-2017 Biosimilar Drug Cost Price Production Value Gross Margin

Chapter Five Asia Biosimilar Drug Key Manufacturers Analysis
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information


Chapter Six Asia Biosimilar Drug Industry Development Trend
6.1 2017-2021 Biosimilar Drug Capacity Production Overview
6.2 2017-2021 Biosimilar Drug Production Market Share Analysis
6.3 2017-2021 Biosimilar Drug Demand Overview
6.4 2017-2021 Biosimilar Drug Supply Demand and Shortage
6.5 2017-2021 Biosimilar Drug Import Export Consumption
6.6 2017-2021 Biosimilar Drug Cost Price Production Value Gross Margin

Part III North American Biosimilar Drug Industry (The Report Company Including the Below Listed But Not All)

Chapter Seven North American Biosimilar Drug Market Analysis
7.1 North American Biosimilar Drug Product Development History
7.2 North American Biosimilar Drug Competitive Landscape Analysis
7.3 North American Biosimilar Drug Market Development Trend

Chapter Eight 2012-2017 North American Biosimilar Drug Productions Supply Sales Demand Market Status and Forecast
8.1 2012-2017 Biosimilar Drug Capacity Production Overview
8.2 2012-2017 Biosimilar Drug Production Market Share Analysis
8.3 2012-2017 Biosimilar Drug Demand Overview
8.4 2012-2017 Biosimilar Drug Supply Demand and Shortage
8.5 2012-2017 Biosimilar Drug Import Export Consumption
8.6 2012-2017 Biosimilar Drug Cost Price Production Value Gross Margin

Chapter Nine North American Biosimilar Drug Key Manufacturers Analysis
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information


Chapter Ten North American Biosimilar Drug Industry Development Trend
10.1 2017-2021 Biosimilar Drug Capacity Production Overview
10.2 2017-2021 Biosimilar Drug Production Market Share Analysis
10.3 2017-2021 Biosimilar Drug Demand Overview
10.4 2017-2021 Biosimilar Drug Supply Demand and Shortage
10.5 2017-2021 Biosimilar Drug Import Export Consumption
10.6 2017-2021 Biosimilar Drug Cost Price Production Value Gross Margin

Part IV Europe Biosimilar Drug Industry Analysis (The Report Company Including the Below Listed But Not All)

Chapter Eleven Europe Biosimilar Drug Market Analysis
11.1 Europe Biosimilar Drug Product Development History
11.2 Europe Biosimilar Drug Competitive Landscape Analysis
11.3 Europe Biosimilar Drug Market Development Trend

Chapter Twelve 2012-2017 Europe Biosimilar Drug Productions Supply Sales Demand Market Status and Forecast
12.1 2012-2017 Biosimilar Drug Capacity Production Overview
12.2 2012-2017 Biosimilar Drug Production Market Share Analysis
12.3 2012-2017 Biosimilar Drug Demand Overview
12.4 2012-2017 Biosimilar Drug Supply Demand and Shortage
12.5 2012-2017 Biosimilar Drug Import Export Consumption
12.6 2012-2017 Biosimilar Drug Cost Price Production Value Gross Margin

Chapter Thirteen Europe Biosimilar Drug Key Manufacturers Analysis
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information


Chapter Fourteen Europe Biosimilar Drug Industry Development Trend
14.1 2017-2021 Biosimilar Drug Capacity Production Overview
14.2 2017-2021 Biosimilar Drug Production Market Share Analysis
14.3 2017-2021 Biosimilar Drug Demand Overview
14.4 2017-2021 Biosimilar Drug Supply Demand and Shortage
14.5 2017-2021 Biosimilar Drug Import Export Consumption
14.6 2017-2021 Biosimilar Drug Cost Price Production Value Gross Margin

Part V Biosimilar Drug Marketing Channels and Investment Feasibility

Chapter Fifteen Biosimilar Drug Marketing Channels Development Proposals Analysis
15.1 Biosimilar Drug Marketing Channels Status
15.2 Biosimilar Drug Marketing Channels Characteristic
15.3 Biosimilar Drug Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals

Chapter Sixteen Development Environmental Analysis
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis

Chapter Seventeen Biosimilar Drug New Project Investment Feasibility Analysis
17.1 Biosimilar Drug Market Analysis
17.2 Biosimilar Drug Project SWOT Analysis
17.3 Biosimilar Drug New Project Investment Feasibility Analysis

Part VI Global Biosimilar Drug Industry Conclusions

Chapter Eighteen 2012-2017 Global Biosimilar Drug Productions Supply Sales Demand Market Status and Forecast
18.1 2012-2017 Biosimilar Drug Capacity Production Overview
18.2 2012-2017 Biosimilar Drug Production Market Share Analysis
18.3 2012-2017 Biosimilar Drug Demand Overview
18.4 2012-2017 Biosimilar Drug Supply Demand and Shortage
18.5 2012-2017 Biosimilar Drug Import Export Consumption
18.6 2012-2017 Biosimilar Drug Cost Price Production Value Gross Margin

Chapter Nineteen Global Biosimilar Drug Industry Development Trend
19.1 2017-2021 Biosimilar Drug Capacity Production Overview
19.2 2017-2021 Biosimilar Drug Production Market Share Analysis
19.3 2017-2021 Biosimilar Drug Demand Overview
19.4 2017-2021 Biosimilar Drug Supply Demand and Shortage
19.5 2017-2021 Biosimilar Drug Import Export Consumption
19.6 2017-2021 Biosimilar Drug Cost Price Production Value Gross Margin

Chapter Twenty Global Biosimilar Drug Industry Research Conclusions



★調査レポート[世界のバイオシミラー医薬品市場2017] (コード:DIMEN7075668)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のバイオシミラー医薬品市場2017]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆